SEQIRUS for SEQIRUS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY2026 and FY2027 Appropriations, policies related to pandemic preparedness, public health, and influenza preparedness; CBER 2026 Guidance Agenda; funding for biodefense activities; National Influenza Vaccine Modernization Strategy
Foreign entity interest: CSL Limited and its subsidiaries and affiliates benefit from the financial success of Seqirus.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE FARQUHARSON | — |
| AMY WALKER New | Deputy Scheduler, Sen. John Warner, 2008; Assistant to the Chief of Staff, Sen. Jim Risch, 2009 |
Health Issues HCR
FY2026 and FY2027 Appropriations, policies related to pandemic preparedness, public health, and influenza preparedness; CBER 2026 Guidance Agenda; funding for biodefense activities; National Influenza Vaccine Modernization Strategy; nominations for HHS Assistant Secretary for the Administration for Strategic Preparedness and Response and Director for the Centers for Disease Control and Prevention
Foreign entity interest: CSL Limited and its subsidiaries and affiliates benefit from the financial success of Seqirus.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE FARQUHARSON | — |
| AMY WALKER New | Deputy Scheduler, Sen. John Warner, 2008; Assistant to the Chief of Staff, Sen. Jim Risch, 2009 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.